PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33030105-0	2022	Molecular dynamics analysis predicts ritonavir and naloxegol strongly block the SARS-CoV-2 spike protein-hACE2 binding.	Ritonavir	37-46	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	91-96	
33679150-5	2021	In this study, we docked five clinically used drug molecules, favipiravir, hydroxychloroquine, remdesivir, lopinavir, and ritonavir onto three target proteins, the receptor-binding domain of SARS-CoV-2 spike protein, SARS-CoV-2 main protease, and human furin protease.	Ritonavir	122-131	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	202-207